AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04378725 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: School-based smoking prevention and cessation program (The KOTAK program)
Description: Advance Intervention: Following the screening process, this intervention package was inclusive of group-briefing for the smokers in at least 3 subsequent sessions in one academic year. The content delivered by the dentist were based on the KOTAK guidebook consisted of 8 Modules.The modules were as follows:~1. Introduction: Identifying students who smoke~2. Cigarette and addiction~3. The danger of smoking and passive smokers~4. Advantages of smoke-free lifestyle and adolescent perception on smoking~5. Legal and religious perception of smoking~6. The benefits of smoking cessation~7. Preparation and how to stop smoking~8. Nicotine withdrawal symptom and relapse prevention~The Intervention schools: Screened smokers were given Advanced Intervention sessions. After discussion with the State's oral health deputy director and district's programme coordinator, for the purpose of this study, the interval of the Advance Intervention session was decided at 1-month interval.
Study NCT02182492 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Clarithromycin
Description: Clarithromycin 250 mg tablet once daily for 3 months
Study NCT02182492 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Glucocorticoid
Description: Fluticasone propionate nasal spray 200 μg/d for 3 months
Study NCT01740492 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ketamine 0.3mg/kg
Description: 0.3 mg/kg ketamine delivered IV (in the vein) following clinician assessment in ER. Number of cycles: until discharge or 6 hours elapses.
Study NCT01740492 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo injection of 0.9% normal saline of a similar volume (0.05ml/kg)
Study NCT00476684 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: radiofrequency treatment
Description: Radiofrequency-neurotomy of the medial branch at 80 degr. C needle temperature for 70 seconds, after diagnostic blocks
Study NCT00620477 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: injection in the knee joint with 20 ml of chirocaine 0.125%
Description: injection in the knee joint with 20 ml of chirocaine 0.125%
Study NCT00620477 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: injection in the knee joint with 20 ml of physiological fluid
Description: injection in the knee joint with 20 ml of physiological fluid
Study NCT02544906 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Propofol
Description: Infusion of propofol to prevent emergence agitation in liver transplanta recipients
Study NCT00476684 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: sham neurotomy
Description: Radiofrequency-neurotomy of the medial branch at 37 degr. C needle temperature for 70 seconds, after diagnostic blocks
Study NCT02544906 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: dexmedetomedine
Description: Infusion of dexmedetomedine to prevent emergence agitation in liver transplanta recipients
Study NCT02616094 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Multi-method Neuroendocrine and Neuroimaging Procedure Scan 1
Description: The MRI scan will be conducted on a 3-T Siemens Trio MRI system equipped with a standard quadrature head coil, using T1 MPRAGE sequence for structural scanning and T2\*-sensitive gradient-recalled single shot echo planar pulse sequence for functional scans. Two multimethod MRI scans will be conducted in the AD sample, while the controls will participate in a single scan.
Study NCT02616094 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Multi-method Neuroendocrine and Neuroimaging Procedure Scan 1
Description: The MRI scan will be conducted on a 3-T Siemens Trio MRI system equipped with a standard quadrature head coil, using T1 MPRAGE sequence for structural scanning and T2\*-sensitive gradient-recalled single shot echo planar pulse sequence for functional scans. Two multimethod MRI scans will be conducted in the AD sample, while the controls will participate in a single scan.
Study NCT02085707 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Total hip replacement arthroplasty
Description: treatment with total hip replacement arthroplasty with the implant chosen by the institution
Study NCT02085707 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Closed reduction and internal fixation
Description: treatment with closed reduction and internal fixation with 2 cannulated hip pins
Study NCT02783742 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Communication coaching
Description: Study coaches will conduct tailored individual sessions with participating providers to teach and improve communication techniques. Coaches will then shadow or audio-record patient encounters and deliver feedback to providers on their communication during these encounters.
Study NCT02783742 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Communication coaching
Description: Study coaches will conduct tailored individual sessions with participating providers to teach and improve communication techniques. Coaches will then shadow or audio-record patient encounters and deliver feedback to providers on their communication during these encounters.
Study NCT02567435 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiation Therapy
Description: Undergo RT
Study NCT02567435 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Temsirolimus
Description: Given IV
Study NCT02616094 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Multi-method Neuroendocrine and Neuroimaging Procedure Scan 2
Description: The MRI scan will be conducted on a 3-T Siemens Trio MRI system equipped with a standard quadrature head coil, using T1 MPRAGE sequence for structural scanning and T2\*-sensitive gradient-recalled single shot echo planar pulse sequence for functional scans. Two multimethod MRI scans will be conducted in the AD sample, while the controls will participate in a single scan.
Study NCT02616094 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Multi-method Neuroendocrine and Neuroimaging Procedure Scan 2
Description: The MRI scan will be conducted on a 3-T Siemens Trio MRI system equipped with a standard quadrature head coil, using T1 MPRAGE sequence for structural scanning and T2\*-sensitive gradient-recalled single shot echo planar pulse sequence for functional scans. Two multimethod MRI scans will be conducted in the AD sample, while the controls will participate in a single scan.
Study NCT03021226 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Fatherhood Development
Description: Fatherhood Development is a curriculum based program provided by a facilitator through a skill-based education intervention.
Study NCT03021226 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Relationship Enhancement
Description: Relationship Enhancement is a curriculum based program provided by a facilitator through a skill-based education intervention.
Study NCT03021226 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Financial Literacy
Description: Relationship Enhancement is a curriculum based program provided by a facilitator through skill-based education intervention.
Study NCT01452269 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Deaf Weight Wise program
Description: Groups will consist of approximately 13 subjects who meet for 2 hours a week for 16 weeks. Group sessions will be offered at a variety of times and days of the week. A trained, deaf, ASL-fluent counselor will lead the sessions.~Subjects will be asked to complete a food and physical activity diary. Each intervention session will include a weigh-in, group sharing/problem solving, discussion of a weight management topic, and goal setting/action planning for the next week. Periodically, each subject will receive a Personal Feedback Report. Subjects will be able to earn points for complying with various aspects of the program. Points can be redeemed for small prizes (i.e. water bottles).~The maintenance phase consists of two meetings at the beginning of the 6-month maintenance period and three months later. This will consist of a weigh-in, review of self-monitored diet and physical activity, problem solving and goal setting/action planning for their long-term program.
Study NCT02567435 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vincristine Sulfate
Description: Given IV
Study NCT06462001 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Bacillus Calmette-Guerin Vaccine Intravesical
Description: BCG (Oncotice) is administered intravesically as per usual standard of care
Study NCT06462001 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Bacillus Calmette-Guerin Vaccine Intravesical
Description: BCG (Oncotice) is administered intravesically as per usual standard of care
Study NCT06462001 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mitomycin
Description: MMC is administered intravesically as per usual standard of care
Study NCT01633749 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Trivalent influenza subunit vaccine Influvac
Description: 3x 15mcg HA per 0.5 ml,trivalent one injection at Day 1
Study NCT00736333 — intervention group
Intervention type: DRUG
Intervention: Pegylated Liposomal Doxorubicin
Description: Pegylated Liposomal Doxorubicin (Caelyx) 50 mg/m\^2, given for up to 6 cycles
Study NCT00899288 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: spectroscopy
Description: Nails will be chemically characterized using Raman spectroscopy.
Study NCT04423653 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Telehealth home exercise program
Description: The intervention will include videos of exercises and also live coaching using telehealth system.
Study NCT04423653 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Telehealth home exercise program
Description: The intervention will include videos of exercises and also live coaching using telehealth system.
Study NCT01481831 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Palonosetron Hydrochloride
Description: 0.25 mg IV\*1 dose on day 1, 30 minutes prior to the administration of the major chemotherapeutic agent.
Study NCT01481831 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Palonosetron Hydrochloride
Description: 0.25mg IV\*3 doses on days 1,3 and 5,30 minutes prior to the administration of the major chemotherapeutic agent.
Study NCT02856997 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chidamide with ICE regimen
Description: Chidamide and ICE regimen, dosage described in arm description
Study NCT01498419 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Moxifloxacin (M)
Study NCT01498419 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pretomid (Pa)
Study NCT01498419 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pyrazinamide (Z)
Study NCT01498419 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Rifafour
Description: Rifafour e-275 once daily for 8 weeks. Daily dose dependent on weight as follows: 30-37kg: 2 tablets, 38-54 kg: 3 tablets, 55-70 kg: 4 tablets: 71 kg and over: 5 tablets
Study NCT02182258 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BIBF 1120 soft gelatine capsule
Study NCT02182258 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: BIBF 1120 intravenous solution
Study NCT02182258 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo ampoule
Study NCT04549909 — intervention group
Intervention type: OTHER
Intervention: collect retrospectively data
Description: Analyse the incidence of BPL in these populations
Study NCT03768219 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: APVO210
Description: APVO210
Study NCT03490552 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: mechanical thrombectomy
Description: Mechanical thrombectomy whatever it type ( SRT , ASPT or Mixed )will be used to extract the thrombi from stroke causing occlusion to be preserved biologically for genomic lab. transfer to be processed by RNA sequencing analysis technique for identifying markers for its composition pointing to its source.
Study NCT03490552 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: mechanical thrombectomy
Description: Mechanical thrombectomy whatever it type ( SRT , ASPT or Mixed )will be used to extract the thrombi from stroke causing occlusion to be preserved biologically for genomic lab. transfer to be processed by RNA sequencing analysis technique for identifying markers for its composition pointing to its source.
Study NCT03324568 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Parent Education Videos
Description: Participants will receive educational videos describing behavioral techniques to improve parent and child eating behavior.
Study NCT03324568 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Educational Handout
Description: Participants will receive educational handouts describing behavioral techniques to improve parent and child eating behavior.
Study NCT03324568 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Educational Handout
Description: Participants will receive educational handouts describing behavioral techniques to improve parent and child eating behavior.
Study NCT03688308 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Arthroscopic rotator cuff repair with bone marrow aspirate concentrate
Description: Subjects will undergo shoulder arthroscopy for rotator cuff repair using a double row technique. Subjects will also be injected with bone marrow aspirate concentrate harvested from the pelvis and centrifuged prior to injection in the shoulder (produced using the Harvest/Terumo BCT system)
Study NCT03688308 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Arthroscopic rotator cuff repair
Description: Subjects will undergo shoulder arthroscopy for rotator cuff repair using a double row technique.
Study NCT02320305 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: MART-1 Antigen
Description: Given IM
Study NCT02685254 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Structural skills training group
Description: Weekly 2-hours sessions for 14 weeks follow the Norwegian translation of the Swedish version of the ADHD skills training manual/workbook (Hesslinger 2010; Hirvikoski 2011; Morgensterns 2015) which is based on an adaption of Marsha Linehan's dialectical behavior therapy (DBT) for borderline personality disorder into a group-based skills training program for adults with ADHD (Hesslinger 2002; Philipsen 2007). The groups embrace 7 - 10 participants, and two group leaders trained in group therapy, cognitive-behavioral treatment or DBT. Each session contains an initial short repetition and feedback on the previous session, followed by review of the homework during the first hour. After a break, a new topic with exercises and homework for the following week is introduced.
Study NCT02685254 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Treatment as usual
Description: Treatment as usual includes clinical management and/or medication, and or supportive counselling by physician or nurse
Study NCT02320305 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TLR4 Agonist GLA-SE
Description: Given IM
Study NCT02320305 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Laboratory Biomarker Analysis
Description: Correlative studies
Study NCT00302848 — intervention group
Intervention type: DRUG
Intervention: Drospirenone
Study NCT00302848 — intervention group
Intervention type: DRUG
Intervention: Levonorgestrel
Study NCT00302848 — intervention group
Intervention type: DRUG
Intervention: Other progestin containing oral contraceptive
Study NCT00726856 — intervention group
Intervention type: DRUG
Intervention: Ezetimibe 10 mg plus statin or ezetimibe 10 mg plus fenofibrate
Description: Ezetimibe 10 mg taken daily for 3 months
Study NCT04404543 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SYHA1807
Description: Escalation Cohort Administration: Orally
Study NCT04404543 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SYHA1807
Description: Dose Expansion Cohort Administration: Orally
Study NCT03682094 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VSL#3
Description: Probiotics are dietary supplements composed of live microorganisms that are normally found within the human microbiome. Probiotics, specifically Lactobacilli and Streptococcus salivarius, have been shown to alter oral microbial composition and to inhibit oral pathogens that contribute to dental caries and periodontal disease. The probiotic chosen for this study is VSL#3, a blend of 8 strains of bacteria, including Lactobacillus and Streptococcus salivarius. VSL#3 has been well tolerated, with minimal adverse effects. VLS#3 was chosen as the treatment substance for this project due to its successful use in trials examining an array of outcomes and its combination of several strains of bacteria.
Study NCT04601155 — intervention group
Intervention type: DEVICE
Intervention: AlloSure
Description: AlloSure is an analytically validated targeted next-generation sequencing (NGS) assay that uses single-nucleotide polymorphisms (SNPs) to measure the fraction of dd-cfDNA in transplant patients without the need for genotyping either the donor or the recipient.8
Study NCT00244075 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: nutritional supplement
Description: either oral nutritional formula (Nepro) or intravenous IDPN solution will be administered during hemodialysis; Nepro has a total calorie amount as well as protein, carbohydrate and fat content that are comparable to that of IDPN, and will be provided at four equal amounts with 1-hour intervals throughout the study (150 ml for a total of 600 ml over 4 hours of hemodialysis); IDPN consists of 225 ml of amino acids at a concentration of 15%, 112.5 ml of dextrose at 50% and 112.5 ml of lipids at 20%, will be given at a rate of 150 ml/hr, and will provide 209 kcal/hr
Study NCT00244075 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: recombinant human growth hormone (rcGH)
Description: subcutaneous administration of 75 micrograms/kg/day of rcGH for 3 consecutive days
Study NCT00244075 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: exercise
Description: either dual leg press (3 sets of 8-12 repetitions) beginning 30 minutes prior to hemodialysis, or modified stepper (minimum of 15 minutes up to a maximum of 90 minutes, depending upon the patient's tolerance) beginning 15 minutes post initiation of hemodialysis
Study NCT03903133 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Vitamin E
Description: vitamin E supplementation for three months (400-600 mg/day) (400 mg/day in those weighed less than 20 kg and 600 mg/day in those weighed at least 20 kg)
Study NCT04196400 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: steroid betamethasone
Description: The steroid is injected using insulin needle in the subcutaneous tissue after finishing the repair
Study NCT01930773 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Genotyping
Description: Patients harboring CYP2C19 \*2 alleles receive 60 mg prasugrel for PCI, while non-carriers receive 600 mg clopidogrel if not pretreated with clopidogrel.
Study NCT01930773 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Phenotyping
Description: Patients having high on-treatment platelet reactivity (HPR: greater than 208 PRU) receive 60 mg prasugrel loading dose (LD), others continue clopidogrel for PCI.
Study NCT04834323 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: distal mesogastric fixation after sleeve gastrectomy
Description: Investigators performed traditional laparoscopic sleeve gastrectomy then we fixed the greater omentum \& mesocolon that were cut during gastrectomy to the remaining gstric pouch along the new greater curvature as high as possible along the stable line then we plicated the remaining staple line till angle of His. (the greater omentum \& mesocolon not reach this part of staple line) , so the remaining gastric pouch remained tension free and was returned to original position and this may prevent the axial gastric rotation
Study NCT03222518 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Paracetamol
Description: 21 pills of Paracetamol 1000mg are provided with a preconised dose of 1 pill 3 times per day over 7 days period
Study NCT03222518 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: NSAID
Description: 14 pills of piroxicam 20 mg are provided with a preconised dose of 1 pill 2times per day over 7 days period
Study NCT03222518 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: paracetamol-NSAID
Description: 21 identical pills of paracetamol ith a preconised dose of 1 pill 3 times per day over 7 days period+14 pills of piroxicam 20 mg are provided with a preconised dose of 1 pill 2times per day over 7 days period
Study NCT02129738 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: LoFric catheters
Description: LoFric single use catheters to be used 4-6 times daily for 4 weeks.
Study NCT02508480 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Photovoice
Description: The 10-session, peer-led Photovoice program, designed to empower individuals with SMI to confront public prejudice and discrimination and reduce personal stigma (self-stigma and perceived stigma), was developed and pilot tested at our Center, with primary contributions from staff with a lived experience of mental illness.~In the Photovoice sessions, participants will be given a workbook titled Combating Prejudice and Discrimination through Photovoice Empowerment. Peer leaders will facilitate discussions based on topics in the workbook. Participants will be given cameras and guidance on taking pictures and writing narratives descriptions about the pictures, specifically the ways in which the pictures relate to experiences of prejudice and discrimination.